Literature DB >> 22488370

The trans-sphenoidal resection of pituitary adenomas in elderly patients and surgical risk.

M Locatelli1, G Bertani, G Carrabba, P Rampini, M Zavanone, M Caroli, E Sala, E Ferrante, S M Gaini, A Spada, G Mantovani, A Lania.   

Abstract

In western countries, the process of "ageing of the population" is increasingly forcing clinical medicine to find answers for pathologies affecting the elder segments of our community. In this respect, pituitary adenomas often raise difficult questions on surgical indications, since little is known about postoperative morbidity and mortality in elderly patients. The transsphenoidal endonasal approach (TNS), which is considered the gold standard for surgical resection of the majority of functioning and non-functioning pituitary adenomas, is supposed to be a low morbidity and mortality procedure in adult patients. However, only a few contradicting data are available in the literature about elderly patients. In this paper we retrospectively analyze a cohort of 43 consecutive patients aged more than 65 years, operated on for pituitary adenomas at our Institution in the years 1998-2007. These patients were treated by transsphenoidal endonasal approach (TNS) for resection of non-functioning pituitary adenomas (n = 31), GH-secreting adenomas (n = 4) and ACTH-secreting adenomas (n = 8). Clinical records reported a macroadenoma with tumour-related mass symptoms in about 80 % of patients; single or multiple pituitary deficits were present in 44 % of patients. Regarding comorbidities, cardiac disease was the most frequently observed (86 %); assessment of anaesthesiological risk indicated a moderate to severe ASA score in most patients, 11 % showing a 4-5 score. On the basis of current criteria, our retrospective analysis revealed that cure was achieved in 54 % of patients. The outcome was similar to that observed in the general population of patients undergoing transphenoidal surgery in our centre, without differences in the rate of surgical and endocrinological cure, minor and major surgical complications and hospitalization duration. In particular, no significant anaesthesiological complications were observed and no patient developed either permanent diabetes insipidus or cerebrospinal fluid rhinorrhea. In conclusion, in specialized centres the surgical treatment of pituitary adenomas via the transsphenoidal route can be a safe and effective procedure even in elderly patients.

Entities:  

Mesh:

Year:  2013        PMID: 22488370     DOI: 10.1007/s11102-012-0390-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  19 in total

1.  Pituitary tumours in the elderly: a 20 year experience.

Authors:  H E Turner; C B Adams; J A Wass
Journal:  Eur J Endocrinol       Date:  1999-05       Impact factor: 6.664

2.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

Authors:  S KATZ; A B FORD; R W MOSKOWITZ; B A JACKSON; M W JAFFE
Journal:  JAMA       Date:  1963-09-21       Impact factor: 56.272

Review 3.  Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature.

Authors:  Giuseppe Minniti; Vincenzo Esposito; Manolo Piccirilli; Amato Fratticci; Antonio Santoro; Marie-Lise Jaffrain-Rea
Journal:  Eur J Endocrinol       Date:  2005-12       Impact factor: 6.664

4.  Surgery: Risks of pituitary surgery in the elderly.

Authors:  Pamela U Freda; Jeffrey N Bruce
Journal:  Nat Rev Endocrinol       Date:  2010-11       Impact factor: 43.330

5.  Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors.

Authors:  Emanuele Ferrante; Monica Ferraroni; Tristana Castrignanò; Laura Menicatti; Mascia Anagni; Giuseppe Reimondo; Patrizia Del Monte; Donatella Bernasconi; Paola Loli; Marco Faustini-Fustini; Giorgio Borretta; Massimo Terzolo; Marco Losa; Alberto Morabito; Anna Spada; Paolo Beck-Peccoz; Andrea G Lania
Journal:  Eur J Endocrinol       Date:  2006-12       Impact factor: 6.664

Review 6.  Surgical treatment of pituitary tumours.

Authors:  Michael Buchfelder; Sven Schlaffer
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-10       Impact factor: 4.690

7.  Clinical analysis of 103 elderly patients with pituitary adenomas: transsphenoidal surgery and follow-up.

Authors:  Jingfang Hong; Xuehua Ding; Yicheng Lu
Journal:  J Clin Neurosci       Date:  2008-08-06       Impact factor: 1.961

8.  Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).

Authors:  Alberto Fernandez; Niki Karavitaki; John A H Wass
Journal:  Clin Endocrinol (Oxf)       Date:  2009-07-24       Impact factor: 3.478

Review 9.  Guidelines for acromegaly management: an update.

Authors:  S Melmed; A Colao; A Barkan; M Molitch; A B Grossman; D Kleinberg; D Clemmons; P Chanson; E Laws; J Schlechte; M L Vance; K Ho; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

10.  Surgical treatment of pituitary tumors in the elderly: clinical outcome and long-term follow-up.

Authors:  Luigi Ferrante; Giuseppe Trillò; Epimenio Ramundo; Paolo Celli; Marie-Lise Jaffrain-Rea; Maurizio Salvati; Vincenzo Esposito; Raffaele Roperto; Mattia Falchetto Osti; Giuseppe Minniti
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

View more
  12 in total

1.  Anatomical study of pterygoid canal (PC) and palatovaginal canal (PVC) in endoscopic trans-sphenoidal approach.

Authors:  Ye Cheng; Haijun Gao; Ge Song; Yunqian Li; Gang Zhao
Journal:  Surg Radiol Anat       Date:  2015-12-22       Impact factor: 1.246

2.  Optic canal (OC) and internal carotid artery (ICA) in sellar region.

Authors:  Ye Cheng; Min Liu; Siwen Zhang; Yong Tian; Da Song; Youqiong Li; Qi Luo
Journal:  Surg Radiol Anat       Date:  2013-09-05       Impact factor: 1.246

Review 3.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

4.  Pituitary adenomas in elderly patients: clinical and surgical outcome analysis in a large series.

Authors:  Alfio Spina; Marco Losa; Pietro Mortini
Journal:  Endocrine       Date:  2019-06-17       Impact factor: 3.633

5.  MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineation.

Authors:  David Calligaris; Daniel R Feldman; Isaiah Norton; Olutayo Olubiyi; Armen N Changelian; Revaz Machaidze; Matthew L Vestal; Edward R Laws; Ian F Dunn; Sandro Santagata; Nathalie Y R Agar
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

6.  Surgical management of pituitary adenomas: does age matter?

Authors:  Valentina Tardivo; Federica Penner; Diego Garbossa; Giuseppe Di Perna; Paolo Pacca; Luca Salvati; Roberto Altieri; Silvia Grottoli; Francesco Zenga
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

7.  Impact of age on postsurgical outcomes of nonfunctioning pituitary adenomas.

Authors:  E Biamonte; N Betella; D Milani; G B Lasio; S Ariano; S Radice; E Lavezzi; G Mazziotti; A Lania
Journal:  Endocrine       Date:  2020-11-26       Impact factor: 3.633

8.  Outcome of Elderly Patients with Meningioma after Image-Guided Stereotactic Radiotherapy: A Study of 100 Cases.

Authors:  David Kaul; Volker Budach; Lukas Graaf; Johannes Gollrad; Harun Badakhshi
Journal:  Biomed Res Int       Date:  2015-05-26       Impact factor: 3.411

9.  Safe Corridor to Access Clivus for Endoscopic Trans-Sphenoidal Surgery: A Radiological and Anatomical Study.

Authors:  Ye Cheng; Siwen Zhang; Yong Chen; Gang Zhao
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

10.  Endoscopic endonasal transsphenoidal surgery for patients aged over 80 years with pituitary adenomas: Surgical and follow-up results.

Authors:  Kenji Fujimoto; Shigetoshi Yano; Naoki Shinojima; Takuichiro Hide; Jun-Ichi Kuratsu
Journal:  Surg Neurol Int       Date:  2017-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.